An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

Overview of attention for article published in Virology Journal, July 2010

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 20,135 followers.

@rferrisx @Daoyu15 @ydeigin @MonaRahalkar @R_H_Ebright 6. Lindsley F. Kimball Research Institute, New York Blood Center https://t.co/JIq7YeMhYB 7. Lanying Du: H5N1 peptide vaccine for pandemic 2009 H1N1 https://t.co/WKgkQrk4SS https://t.co/MpilhbC20k

10 Jul 2022

Reply Repost Favourite

RT @BillyBostickson: and Lanying Du An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infe…

13 Mar 2021

Reply Repost Favourite

and Lanying Du An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus https://t.co/IOMJgSlQMD

13 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.